Role OF LAGHU VISHAGARBHA TAILA AND MARMA THERAPY IN THE MANAGEMENT OF SANDHIGATA VATA w.s.r. TO OSTEOARTHRITIS
- Conditions
- Osteoarthritis, unspecified site,
- Registration Number
- CTRI/2019/05/019131
- Lead Sponsor
- Uttrakhand Ayurved University
- Brief Summary
Sandigata Vatais a common condition which can be correlated with osteoarthritis. Sandhigatavata is a common type of Vatic disorderafflicting the society. Owning to distracting nature and difficult anagement atavyadhi has been included in Asht mahagad. Osteoarthritis is a joint failure, adisease in which all structures of the joint have under gone pathology change.This is accompanied by increasing thickness and sclerosis of the subchondralbony plate, by outgrowth of osteophytes at the joint margin, by stretching ofthe articular capsule, by mild synovitis in many affected joints, and by theweakness of muscles bridging the joint. OA is a long term chronic diseasecharacterized by the deterioration of cartilage in joints which result in bonesrubbing together and creating stiffness, pain and impaired movement. Thedisease most commonly affects the joints in the knees, hands, feet, and spineand is related to ageing. It is also associated with a variety of both modifiableand non-modifiable risk factors, including obesity lack of exercise, geneticpredisposition, bone density, occupational injury, trauma and gender.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
INCLUSION CRITERIA- 1.Patients fulfilling the diagnostic criteria of Sandhigata Vata (OA) 2.Patients aged between 30 -70 years will be included of either sex.
- EXCLUSION CRITERIA- 1.Patients having history of joint trauma, secondary and other systemic illness.
- 2.Patients suffering from any systemic diseases like tuberculosis, rheumatoid arthritis, gouty arthritis, psoriatic arthritis .
- 3.Patient suffering from infectious osteoarthritis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete remission:100% relief Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief Markedly improved:76-99% relief Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief Moderately improved:51%-75% relief Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief Improved:26%-50% relief Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief Unchanged:0% – 25% relief Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief
- Secondary Outcome Measures
Name Time Method Exacerbation in sign and symptom 90 days
Trial Locations
- Locations (1)
Rishikul Ayurvedic Hospital
🇮🇳Hardwar, UTTARANCHAL, India
Rishikul Ayurvedic Hospital🇮🇳Hardwar, UTTARANCHAL, IndiaUrvashiPrincipal investigator9761055936urvashipanwar2009@gmail.com